Your browser is no longer supported. Please, upgrade your browser.
Settings
SILK [NASD]
Silk Road Medical, Inc
Index- P/E- EPS (ttm)-1.21 Insider Own1.20% Shs Outstand33.76M Perf Week-6.62%
Market Cap1.81B Forward P/E- EPS next Y-0.68 Insider Trans-31.75% Shs Float32.50M Perf Month-10.48%
Income-38.90M PEG- EPS next Q-0.28 Inst Own- Short Float7.74% Perf Quarter-10.75%
Sales72.70M P/S24.85 EPS this Y-83.40% Inst Trans1.23% Short Ratio7.80 Perf Half Y-2.62%
Book/sh3.55 P/B14.97 EPS next Y44.30% ROA-24.50% Target Price67.83 Perf Year14.13%
Cash/sh4.53 P/C11.74 EPS next 5Y- ROE-40.70% 52W Range20.84 - 75.80 Perf YTD-15.62%
Dividend- P/FCF- EPS past 5Y- ROI-24.00% 52W High-29.89% Beta-
Dividend %- Quick Ratio11.10 Sales past 5Y- Gross Margin71.40% 52W Low154.99% ATR3.11
Employees224 Current Ratio11.80 Sales Q/Q18.20% Oper. Margin-48.70% RSI (14)37.43 Volatility5.40% 5.63%
OptionableYes Debt/Eq0.38 EPS Q/Q-17.40% Profit Margin-53.50% Rel Volume1.33 Prev Close54.57
ShortableYes LT Debt/Eq0.38 EarningsMar 01 AMC Payout- Avg Volume322.58K Price53.14
Recom2.00 SMA20-7.10% SMA50-9.87% SMA200-3.02% Volume429,258 Change-2.62%
Oct-01-20Downgrade Citigroup Buy → Neutral $58 → $71
Aug-21-20Initiated Piper Sandler Neutral $54
Jul-09-20Initiated SVB Leerink Outperform $51
May-27-20Initiated Citigroup Buy $50
Aug-20-19Initiated Argus Buy $52
Apr-29-19Initiated Stifel Buy $44
Apr-29-19Initiated JP Morgan Overweight $45
Apr-29-19Initiated BofA/Merrill Neutral $43
Apr-29-19Initiated BMO Capital Markets Outperform
Feb-16-21 04:05PM  
Feb-15-21 09:48PM  
Feb-13-21 03:30PM  
Feb-11-21 01:39PM  
Feb-08-21 07:00PM  
Feb-06-21 11:05PM  
Feb-05-21 03:55AM  
Feb-03-21 12:33PM  
Jan-28-21 11:05PM  
Jan-25-21 11:54PM  
Jan-23-21 11:45PM  
Jan-20-21 11:47PM  
Dec-28-20 08:23AM  
Dec-25-20 07:51AM  
Dec-18-20 01:06PM  
Dec-17-20 04:05PM  
Dec-03-20 04:05PM  
Dec-02-20 12:32PM  
Nov-13-20 08:24AM  
Nov-10-20 07:30PM  
05:35PM  
04:55PM  
04:05PM  
02:30PM  
Nov-06-20 11:49AM  
Nov-04-20 04:05PM  
Nov-03-20 12:31PM  
Oct-20-20 04:05PM  
Oct-12-20 01:00PM  
Oct-01-20 04:05PM  
Sep-21-20 04:05PM  
09:00AM  
Sep-04-20 08:00AM  
Aug-26-20 09:01PM  
Aug-21-20 09:32AM  
Aug-19-20 04:05PM  
Aug-05-20 10:15PM  
08:01PM  
04:05PM  
Jul-29-20 12:33PM  
Jul-23-20 04:35PM  
Jul-22-20 12:01PM  
Jul-09-20 04:05PM  
Jul-05-20 06:41PM  
Jul-03-20 07:18PM  
Jun-30-20 04:05PM  
Jun-16-20 03:09PM  
Jun-15-20 08:27PM  
Jun-05-20 10:17AM  
May-20-20 04:05PM  
May-08-20 08:39PM  
04:05PM  
May-06-20 12:52PM  
01:15AM  
May-05-20 04:22PM  
May-01-20 11:30AM  
Apr-30-20 04:05PM  
Apr-29-20 04:05PM  
Apr-27-20 08:42AM  
Apr-26-20 07:50PM  
Apr-23-20 12:32PM  
Apr-21-20 06:15PM  
Apr-06-20 08:00AM  
Mar-20-20 03:15PM  
Mar-06-20 08:49AM  
Mar-05-20 10:00PM  
Mar-01-20 09:50AM  
Feb-28-20 12:00PM  
Feb-26-20 04:05PM  
Feb-13-20 04:05PM  
Jan-30-20 04:28PM  
Jan-10-20 02:53PM  
Jan-03-20 10:15AM  
Dec-27-19 09:17AM  
Dec-26-19 09:53AM  
Dec-19-19 04:05PM  
Dec-17-19 05:01PM  
04:08PM  
Dec-11-19 08:58PM  
Dec-09-19 08:00AM  
Nov-22-19 12:24PM  
Nov-14-19 09:46AM  
Nov-05-19 04:05PM  
Nov-01-19 12:08PM  
Oct-29-19 04:03PM  
Oct-28-19 08:14PM  
Oct-14-19 04:05PM  
Oct-07-19 04:10PM  
Sep-05-19 01:34PM  
Sep-04-19 02:59PM  
06:00AM  
Aug-19-19 10:41AM  
Aug-13-19 04:05PM  
Aug-08-19 06:33PM  
Aug-06-19 04:29PM  
Jul-30-19 02:47PM  
Jul-29-19 04:03PM  
Jul-25-19 01:06PM  
Jul-22-19 04:03PM  
Jul-17-19 08:01AM  
Silk Road Medical, Inc. operates as a medical device company in the United States. The company offers various products for the treatment of carotid artery disease called transcarotid artery revascularization. Its products includes ENROUTE Transcarotid Neuroprotection System that is used to directly access the common carotid artery and initiate temporary blood flow reversal; ENROUTE Transcarotid Stent System, a self-expanding, self-tapering stent with clinical data regarding lasting safety outcomes; ENHANCE Transcarotid Peripheral Access Kit for use in gaining initial access to the common carotid artery; and ENROUTE 0.014 Guidewire for navigating and crossing the target lesion for delivery of interventional devices. The company was founded in 2007 and is headquartered in Sunnyvale, California.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Buchanan Lucas W.COO/CFOFeb 17Option Exercise1.6010,00016,000164,606Feb 19 06:16 PM
Rogers Erica J.President and CEOFeb 11Option Exercise1.6011,00017,600122,608Feb 12 07:38 PM
Rogers Erica J.President and CEOFeb 11Sale59.5511,000655,058111,608Feb 12 07:38 PM
Davis Andrew S.Chief Commercial OfficerFeb 01Option Exercise1.467,47210,90927,274Feb 02 06:17 PM
Davis Andrew S.Chief Commercial OfficerFeb 01Sale54.127,472404,39219,802Feb 02 06:17 PM
Buchanan Lucas W.COO/CFOJan 27Option Exercise4.7310,00047,300164,606Jan 29 06:03 PM
Buchanan Lucas W.COO/CFOJan 27Sale54.8610,000548,623154,606Jan 29 06:03 PM
Rogers Erica J.President and CEOJan 11Option Exercise1.6011,00017,600122,608Jan 13 09:03 PM
Rogers Erica J.President and CEOJan 11Sale59.6611,000656,291111,608Jan 13 09:03 PM
Davis Andrew S.Chief Commercial OfficerJan 04Option Exercise1.467,47210,90927,274Jan 05 08:28 PM
Davis Andrew S.Chief Commercial OfficerJan 04Sale59.677,472445,86719,802Jan 05 08:28 PM
Buchanan Lucas W.COO/CFODec 29Option Exercise3.3418,00060,100156,606Dec 30 09:08 PM
Buchanan Lucas W.COO/CFODec 29Sale60.0410,000600,364146,606Dec 30 09:08 PM
Buchanan Lucas W.COO/CFODec 14Option Exercise1.607,00011,200146,606Dec 15 06:57 PM
Rogers Erica J.President and CEODec 11Option Exercise1.4911,00016,400120,180Dec 15 06:16 PM
Buchanan Lucas W.COO/CFODec 11Option Exercise1.607,00011,200139,606Dec 15 06:57 PM
Rogers Erica J.President and CEODec 11Sale58.3511,000641,867111,608Dec 15 06:16 PM
Davis Andrew S.Chief Commercial OfficerDec 01Option Exercise1.467,47210,90927,274Dec 03 06:59 PM
Davis Andrew S.Chief Commercial OfficerDec 01Sale56.637,472423,11219,802Dec 03 06:59 PM
Buchanan Lucas W.COO/CFONov 25Option Exercise4.7310,00047,300142,523Nov 30 05:48 PM
Buchanan Lucas W.COO/CFONov 25Sale57.0810,000570,826132,523Nov 30 05:48 PM
Ruedy RichardEVPClin&Reg.Affairs&QANov 23Option Exercise1.57108,974171,478128,118Nov 24 05:42 PM
Ruedy RichardEVPClin&Reg.Affairs&QANov 17Option Exercise1.4214,22120,21826,551Nov 18 06:20 PM
Ruedy RichardEVPClin&Reg.Affairs&QANov 17Sale59.8414,221850,97219,144Nov 18 06:20 PM
Rogers Erica J.President and CEONov 11Option Exercise1.4611,00016,060122,608Nov 13 08:22 PM
Rogers Erica J.President and CEONov 11Sale63.4411,000697,820111,608Nov 13 08:22 PM
Davis Andrew S.Chief Commercial OfficerNov 02Option Exercise1.466,6409,69426,442Nov 04 06:51 PM
Davis Andrew S.Chief Commercial OfficerNov 02Sale61.376,640407,48419,802Nov 04 06:51 PM
Buchanan Lucas W.COO/CFOOct 14Option Exercise4.739,60045,408117,898Oct 16 06:38 PM
Buchanan Lucas W.COO/CFOOct 14Sale65.219,600626,020111,027Oct 16 06:38 PM
Rogers Erica J.President and CEOOct 12Option Exercise1.4620,04429,264131,652Oct 13 06:11 PM
Rogers Erica J.President and CEOOct 12Sale66.1620,0441,326,133111,608Oct 13 06:11 PM
Davis Andrew S.Chief Commercial OfficerOct 01Option Exercise1.466,6359,68726,437Oct 02 05:37 PM
Davis Andrew S.Chief Commercial OfficerOct 01Sale65.606,635435,23919,802Oct 02 05:37 PM
Buchanan Lucas W.Chief Financial OfficerSep 17Option Exercise4.739,60045,408120,627Sep 18 07:36 PM
Buchanan Lucas W.Chief Financial OfficerSep 17Sale67.329,600646,284111,027Sep 18 07:36 PM
Rogers Erica J.President and CEOSep 11Option Exercise1.4520,04428,971127,982Sep 15 06:17 PM
Rogers Erica J.President and CEOSep 11Sale60.9820,0441,222,347111,608Sep 15 06:17 PM
Davis Andrew S.Chief Commercial OfficerSep 01Option Exercise1.466,6359,68726,437Sep 02 05:46 PM
Davis Andrew S.Chief Commercial OfficerSep 01Sale59.726,635396,26219,802Sep 02 05:46 PM
Buchanan Lucas W.Chief Financial OfficerAug 17Option Exercise3.979,60038,143118,306Aug 19 06:31 PM
Buchanan Lucas W.Chief Financial OfficerAug 17Sale53.869,600517,097111,027Aug 19 06:31 PM
Rogers Erica J.President and CEOAug 11Option Exercise1.3820,04427,661131,652Aug 12 07:01 PM
Rogers Erica J.President and CEOAug 11Sale51.4220,0441,030,616111,608Aug 12 07:01 PM
Davis Andrew S.Chief Commercial OfficerAug 03Option Exercise1.466,6359,68725,537Aug 04 05:59 PM
Davis Andrew S.Chief Commercial OfficerAug 03Sale47.796,635317,10218,902Aug 04 05:59 PM
Buchanan Lucas W.Chief Financial OfficerJul 15Option Exercise1.609,60015,360120,627Jul 16 05:38 PM
Buchanan Lucas W.Chief Financial OfficerJul 15Sale45.999,600441,540111,027Jul 16 05:38 PM
Rogers Erica J.President and CEOJul 13Option Exercise1.3820,04427,661131,652Jul 14 07:26 PM
Rogers Erica J.President and CEOJul 13Sale45.4220,044910,443111,608Jul 14 07:26 PM
Davis Andrew S.EVPGlobal Sales& MarketingJul 01Option Exercise1.466,6359,68725,537Jul 06 05:51 PM
Davis Andrew S.EVPGlobal Sales& MarketingJul 01Sale41.956,635278,34318,902Jul 06 05:51 PM
Buchanan Lucas W.Chief Financial OfficerJun 15Option Exercise1.609,60015,360116,016Jun 16 07:27 PM
Buchanan Lucas W.Chief Financial OfficerJun 15Sale36.979,600354,875110,358Jun 16 07:27 PM
Rogers Erica J.President and CEOJun 11Option Exercise1.3820,04427,661130,965Jun 12 06:40 PM
Rogers Erica J.President and CEOJun 11Sale37.2920,044747,441110,921Jun 12 06:40 PM
Davis Andrew S.EVPGlobal Sales& MarketingJun 01Option Exercise1.466,6359,68724,850Jun 03 05:43 PM
Davis Andrew S.EVPGlobal Sales& MarketingJun 01Sale38.676,635256,60418,215Jun 03 05:43 PM
Buchanan Lucas W.Chief Financial OfficerMay 15Option Exercise1.609,60015,360119,958May 19 08:56 PM
Buchanan Lucas W.Chief Financial OfficerMay 15Sale38.619,600370,622110,358May 19 08:56 PM
Rogers Erica J.President and CEOMay 11Option Exercise1.3820,04427,661130,107May 13 06:04 PM
Rogers Erica J.President and CEOMay 11Sale37.6320,044754,250110,921May 13 06:04 PM
WP X Finance, L.P.10% OwnerMay 05Sale39.004,885,078190,518,0421,021,223May 07 08:50 PM
WARBURG PINCUS & CO.10% OwnerMay 05Sale39.004,885,078190,518,0421,021,223May 07 08:50 PM
Davis Andrew S.EVPGlobal Sales& MarketingMay 01Option Exercise1.4613,27019,37431,485May 05 09:12 PM
Davis Andrew S.EVPGlobal Sales& MarketingMay 01Sale41.0313,270544,47518,215May 05 09:12 PM
Buchanan Lucas W.Chief Financial OfficerApr 15Option Exercise1.6019,10030,560129,458Apr 17 08:47 PM
Buchanan Lucas W.Chief Financial OfficerApr 15Sale33.6719,100643,009110,358Apr 17 08:47 PM
Rogers Erica J.President and CEOApr 14Option Exercise1.382,7443,787113,665Apr 15 06:47 PM
Rogers Erica J.President and CEOApr 14Sale35.002,74496,040110,921Apr 15 06:47 PM
Rogers Erica J.President and CEOApr 13Option Exercise1.3817,30023,874128,221Apr 15 06:47 PM
Rogers Erica J.President and CEOApr 13Sale35.0217,300605,808110,921Apr 15 06:47 PM
Buchanan Lucas W.Chief Financial OfficerApr 01Option Exercise1.5416,27325,000110,358Apr 03 05:45 PM
Buchanan Lucas W.Chief Financial OfficerMar 16Option Exercise1.6010016089,510Mar 18 08:09 PM
Buchanan Lucas W.Chief Financial OfficerMar 16Sale30.251003,02589,410Mar 18 08:09 PM
Rogers Erica J.President and CEOMar 11Option Exercise1.3820,04427,661117,590Mar 13 05:36 PM
Rogers Erica J.President and CEOMar 11Sale37.3620,044748,94297,546Mar 13 05:36 PM
Ruedy RichardEVPClin&Reg.Affairs&QAMar 04Option Exercise1.388,00011,04015,794Mar 05 08:36 PM
Davis Andrew S.EVPGlobal Sales& MarketingMar 02Option Exercise1.466,6359,68720,175Mar 03 06:23 PM
Davis Andrew S.EVPGlobal Sales& MarketingMar 02Sale40.336,635267,59013,540Mar 03 06:23 PM